Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity

Autor: Sophie Pezet, Anthony H. Dickenson, James Leiper, Claire A. Sand, Stephen B. McMahon, Manasi Nandi, Egle Gaurilcikaite, Richard DʼMello
Přispěvatelé: Department of Neuroscience, Physiology & Pharmacology, University College of London [London] (UCL), Laboratoire Plasticité du Cerveau Brain Plasticity (UMR 8249) (PdC), Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), Physique pour la médecine (UMR 8063, U1273), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Division of Medicine, Centre for Cancer Research and Cell Biology, Queen's University [Belfast] (QUB), PEZET, Sophie, Physique pour la médecine (PhysMed Paris)
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Male
Nociception
Nervous system
Action Potentials
Rats
Sprague-Dawley

Mice
chemistry.chemical_compound
Nerve Fibers
0302 clinical medicine
Ganglia
Spinal

Cells
Cultured

ComputingMilieux_MISCELLANEOUS
0303 health sciences
Neuronal Plasticity
biology
Chemistry
3. Good health
Nitric oxide synthase
NG-Nitroarginine Methyl Ester
medicine.anatomical_structure
Spinal Cord
Neurology
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Dimethylarginine dimethylaminohydrolase inhibition
Research Paper
Gene isoform
Spinal Cord Dorsal Horn
medicine.medical_specialty
Nerve Tissue Proteins
Amidohydrolases
Nitric oxide
03 medical and health sciences
Asymmetric dimethylargenine
Internal medicine
medicine
Animals
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Nitrites
Neuronal nitric oxide synthase
030304 developmental biology
Spinal cord
Rats
Mice
Inbred C57BL

Disease Models
Animal

Spinal hyperexcitability
Anesthesiology and Pain Medicine
Endocrinology
Gene Expression Regulation
biology.protein
Neurology (clinical)
Nitric Oxide Synthase
Asymmetric dimethylarginine
Neuroscience
030217 neurology & neurosurgery
Zdroj: PAIN
PAIN, Elsevier, 2015, 156 (10), pp.2052-2060. ⟨10.1097/j.pain.0000000000000269⟩
PAIN, 2015, 156 (10), pp.2052-2060. ⟨10.1097/j.pain.0000000000000269⟩
Pain
ISSN: 0304-3959
1872-6623
Popis: Supplemental Digital Content is Available in the Text. Inhibition of dimethylarginine dimethylaminohydrolase 1 attenuates pain-related behavior and hyperexcitability in pain conditions associated with excessive nitric oxide production, representing a novel therapeutic target.
Activation of neuronal nitric oxide synthase, and consequent production of nitric oxide (NO), contributes to spinal hyperexcitability and enhanced pain sensation. All NOS isoforms are inhibited endogenously by asymmetric dimethylarginine, which itself is metabolised by dimethylarginine dimethylaminohydrolase (DDAH). Inhibition of DDAH can indirectly attenuate NO production by elevating asymmetric dimethylarginine concentrations. Here, we show that the DDAH-1 isoform is constitutively active in the nervous system, specifically in the spinal dorsal horn. DDAH-1 was found to be expressed in sensory neurons within both the dorsal root ganglia and spinal dorsal horn; L-291 (NG–[2-Methoxyethyl]-l-arginine methyl ester), a DDAH-1 inhibitor, reduced NO synthesis in cultured dorsal root ganglia neurons. Spinal application of L-291 decreased N-methyl-d-aspartate–dependent postdischarge and windup of dorsal horn sensory neurons—2 measures of spinal hyperexcitability. Finally, spinal application of L-291 reduced both neuronal and behavioral measures of formalin-induced central sensitization. Thus, DDAH-1 may be a potential therapeutic target in neuronal disorders, such as chronic pain, where elevated NO is a contributing factor.
Databáze: OpenAIRE